Clinical Trial Update: G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders [NA]

View source ↗

Summary

Clinical trial update for a study evaluating G-CSF–treated donor bone marrow transplant in hematologic disorders; the trial (NCT00253552) is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Myeloproliferative Neoplasms
• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms
• Sarcoma

Drugs mentioned

• Filgrastim (filgrastim)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease | NA | Status: TERMINATED